LGALS3 and cancer: Thirdly, we observed an increased expression of several immune checkpoints, including PD-L1 (CD274), PD-L2 (PDCD1LG2), CD73 (NT5E), and galectin-3 (LGALS3) in the nutlin-3 resistant cancer cells.